A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer
A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer
复制标题
吉西他滨、S-1 和 LV 联合 (GSL) 新辅助化疗治疗临界可切除局部晚期胰腺癌的 II 期试验
DOI:
10.1007/s12032-018-1158-8
复制
发表时间:
2018
期刊:
影响因子:
3.4
通讯作者:
Koku
中科院分区:
文献类型:
--
作者:
Saito Kei;Isayama Hiroyuki;Sakamoto Yoshihiro;Nakai Yousuke;Ishigaki Kazunaga;Tanaka Mariko;Watadani Takeyuki;Arita Junichi;Takahara Naminatsu;Mizuno Suguru;Kogure Hirofumi;Ijichi Hideaki;Tateishi Keisuke;Tada Minoru;Hasegawa Kiyoshi;Fukayama Masashi;Koku
登录
查看更多内容
影响因子:
8.8
作者:
Nakai Y;Isayama H;Sasaki T;Sasahira N;Tsujino T;Toda N;Kogure H;Matsubara S;Ito Y;Togawa O;Arizumi T;Hirano K;Tada M;Omata M;Koike K
通讯作者:
Koike K
影响因子:
3.1
作者:
Mellon, Eric A.;Jin, William H.;Hoffe, Sarah E.
通讯作者:
Hoffe, Sarah E.
影响因子:
3
作者:
Y. Nakai;H. Isayama;Kei Saito;Takashi Sasaki;N. Takahara;T. Hamada;S. Mizuno;K. Miyabayashi;Keisuke Yamamoto;D. Mohri;H. Kogure;N. Yamamoto;K. Hirano;H. Ijichi;K. Tateishi;M. Tada;K. Koike
通讯作者:
K. Koike
影响因子:
3
作者:
Okusaka, Takuji;Funakoshi, Akihiro;Saito, Hiroshi
通讯作者:
Saito, Hiroshi
DOI:
--
发表时间:
2019
期刊:
--
影响因子:
--
作者:
Doreen Agnese;Kimberly H. Allison;Sarah L. Blair;H. Burstein;Anthony D. Elias;Sharon H. Giordano
通讯作者:
Doreen Agnese;Kimberly H. Allison;Sarah L. Blair;H. Burstein;Anthony D. Elias;Sharon H. Giordano